| Authors: |
Mechahougui H; Oncology Department, Geneva University Hospital, 1205 Geneva, Switzerland. Electronic address: hiba.mechahougui@hug.ch., Friedlaender A; Clinique Générale Beaulieu, 1206 Geneva, Switzerland., Görgülü K; Institute of Metabolism and Cell Death, Helmholtz Zentrum München, Munich, Germany; Comprehensive Cancer Center München, Institute for Tumor Metabolism, Klinikum Rechts der Isar, Technical University of Munich, School of Medicine and Health, Munich, Bavaria, Germany., Tsantoulis P; Oncology Department, Geneva University Hospital, 1205 Geneva, Switzerland; Division of Precision Oncology, Geneva University Hospital, 1205 Geneva, Switzerland., Illert AL; Medical Department for Hematology and Oncology, TUM University Hospital, Klinikum Rechts der Isar, Technische Universität München, Munich, Germany; Department of Hematology and Medical Oncology, University Medical Center Göttingen (UMG), Göttingen, Germany., Subbiah V; Sarah Cannon Research Institute, Nashville, TN, USA. Electronic address: vivek.subbiah@scri.com., Wahida A; Institute of Metabolism and Cell Death, Helmholtz Zentrum München, Munich, Germany; Krantz Family Center for Cancer Research, Massachusetts General Hospital Cancer Center, Massachusetts General Hospital, Boston, MA, USA; Department of Molecular Metabolism, Harvard T.H. Chan School of Public Health, Boston, MA, USA. Electronic address: awahida@mgh.harvard.edu., Kurzrock R; WIN Consortium, Paris, France; Medical College of Wisconsin, Milwaukee, WI, USA. Electronic address: rkurzrock@mcw.edu. |
